Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76301 - 76325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Liothyronine	Approved Investigational Vet Approved	ZNF497	162968	upregulated	Triiodothyronine results in increased expression of ZNF497 mRNA	19q13.43	A20648
Liothyronine	Approved Investigational Vet Approved	ZNF664	144348	upregulated	Triiodothyronine results in increased expression of ZNF664 mRNA	12q24.31	A20648
Liothyronine	Approved Investigational Vet Approved	ZNF676	163223	downregulated	Triiodothyronine results in decreased expression of ZNF676 mRNA	19p12	A20648
Liothyronine	Approved Investigational Vet Approved	ZNF676	163223	upregulated	Triiodothyronine results in increased expression of ZNF676 mRNA	19p12	A20648
Tacrolimus	Approved Investigational	BIRC5	332	downregulated	Tacrolimus results in decreased expression of BIRC5 mRNA	17q25.3	A24372
Tacrolimus	Approved Investigational	CCL11	6356	downregulated	Tacrolimus results in decreased expression of CCL11 mRNA	17q12	A24373
Tacrolimus	Approved Investigational	CCL5	6352	downregulated	Tacrolimus results in decreased expression of CCL5 mRNA	17q12	A24373
Tacrolimus	Approved Investigational	CCNB2	9133	downregulated	Tacrolimus results in decreased expression of CCNB2 mRNA	15q22.2	A24372
Tacrolimus	Approved Investigational	CCR3	1232	downregulated	Tacrolimus results in decreased expression of CCR3 mRNA	3p21.31	A24373
Tacrolimus	Approved Investigational	CYBA	1535	upregulated	Tacrolimus results in increased expression of CYBA mRNA	16q24.2	A21879
Tacrolimus	Approved Investigational	IL5	3567	downregulated	Tacrolimus results in decreased expression of IL5 mRNA	5q31.1	A24373 A24374
Tacrolimus	Approved Investigational	NOS3	4846	upregulated	Tacrolimus results in increased expression of NOS3 mRNA	7q36.1	A21879
Tacrolimus	Approved Investigational	TGFB1	7040	upregulated	Tacrolimus results in increased expression of TGFB1 mRNA	19q13.1	A21879
Talc	Approved Investigational	IL1B	3553	upregulated	Talc analog results in increased expression of IL1B mRNA	2q14.1	A24375
Talc	Approved Investigational	IL6	3569	upregulated	Talc analog results in increased expression of IL6 mRNA	7p15.3	A24375
Talc	Approved Investigational	TNF	7124	upregulated	Talc analog results in increased expression of TNF mRNA	6p21.33	A24375
Tamibarotene	Investigational	ACVRL1	94	downregulated	tamibarotene results in decreased expression of ACVRL1 mRNA	12q13.13	A24376
Tamibarotene	Investigational	ADA	100	upregulated	tamibarotene results in increased expression of ADA mRNA	20q13.12	A24376
Tamibarotene	Investigational	ADGRE1	2015	upregulated	tamibarotene results in increased expression of ADGRE1 mRNA	19p13.3-p13.2	A24376
Tamibarotene	Investigational	AHNAK	79026	downregulated	tamibarotene results in decreased expression of AHNAK mRNA	11q12.3	A24376
Tamibarotene	Investigational	AIF1	199	upregulated	tamibarotene results in increased expression of AIF1 mRNA	6p21.33	A24376
Tamibarotene	Investigational	AK4	205	downregulated	tamibarotene results in decreased expression of AK4 mRNA	1p31.3	A24376
Tamibarotene	Investigational	AKAP9	10142	downregulated	tamibarotene results in decreased expression of AKAP9 mRNA	7q21.2	A24376
Tamibarotene	Investigational	ALAS1	211	upregulated	tamibarotene results in increased expression of ALAS1 mRNA	3p21.2	A24376
Tamibarotene	Investigational	ALMS1	7840	downregulated	tamibarotene results in decreased expression of ALMS1 mRNA	2p13.1	A24376

Displaying entries 76301 - 76325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability